Novo Nordisk reported 162.71B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Bausch Health Companies USD 6.51B 782M Jun/2025
Bristol-Myers Squibb USD 33.22B 2.44B Jun/2025
Eli Lilly USD 49.85B 8.59B Jun/2025
GlaxoSmithKline GBP 17.67B 412M Jun/2025
Merck USD 37.07B 1.56B Jun/2025
Novartis USD 25.94B 831M Jun/2025
Novo Nordisk 162.71B 11.69B Jun/2025
Novo Nordisk DKK 174.4B 20.76B Mar/2025
Pacira USD 745.61M 14.35M Jun/2025
Sanofi 37.02B 7B Jun/2025
Supernus Pharmaceuticals USD 738.87M 51.28M Jun/2025